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Introduction 
Pseudolymphoma is not a specific disease but rather
an inflammatory response to known or unknown stimuli
that results in a lymphomatous-appearing but benign ac-
cumulation of inflammatory cells (1). Resemblance to
lymphoma is usually most apparent histologically, but
some examples may also mimic lymphoma clinically.
When known, the inciting agent should be included
within the diagnosis. 
The term pseudolymphoma without istological al-
terations should be reserved for idiopathic cases. To di-
stinguish a benign from malignant lymphoid lesion el-
sewhere in the body, the integrity of the architecture of
lymph node is an important criterion (2). In the orbit,
however, lymph nodes are not present and histological
distinction, between lymphocytic infiltration from be-
nign and malignant lym phatic tumours is often diffi-
cult.
Case report 
A 33 years male presented with gradually progressive proptosis
of right eye losting four months. Ocular examination shows a firm
irregular and nontender palpable mass above and to the lateral side
of the eyeball, displacing it downwards and slightly outwards; the
movements were equal on both sides. Systemic and haematological
examination revealed no abnor mality. CT exam revealed a patho-
logical structure in the superior eyelid extending medially (Fig. 1). 
An anterior orbitotomy was performed; the histopathological-
ly the lesion consisted of lymphoid tissue, mixed with fibrovascular
septa and adipous areas (Fig. 2 A). The lacrimal gland (Fig. 2 B) was
also involved. Polyclonal B areas, with plasma cells positive to both
kappa (Fig. 2 C) and lambda (Fig. 2 D) immunoglobulin heavy chains
were easily recognizable. The lesion was diagnosed as lymphoid hy-
perplasia. 
The postoperative course was uneventful and the patient was di-
scharged in third day with a therapy with prednisolone without evi-
dence of recurrence after 10 month follow-up.
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Orbital pseudolymphomas are uncommon benign tumors composed
of reactive lymphocytes. The typical clinical presentation is painless onset
of ptosis, proptosis, diplopia, or eyelid swelling. Virtually any adnexal struc-
ture can be affected, but lacrimal gland, orbital soft tissue, or extraocular
muscles are the usual sites of involvement. Historically, treatment has been
with oral corticosteroids or localized radiotherapy. We present a case of be-
nign orbital pseudolymphoma.
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Le lesioni pseudo-linfomatose dell’orbita sono neoplasie benigne piut-
tosto rare. Clinicamente caratterizzata da una sintomatologia costituita
prevalentemente da ptosi, proptosi e diplopia, la lesione può interessare tut-
te le strutture contenute nella cavità orbitaria con possibile coinvolgimento
dei coni muscolari. Alla chirurgia segue un trattamento farmacologico ste-
roideo e una possibile radioterapia locale. Si presenta un caso giunto alla
nostra osservazione.
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Discussion 
Inflammatory or reactive lesions clinically and patho-
logically can mimic malignant tumors and are descri-
bed by a variety of terms, including inflammatory pseu-
dotumor or pseudolymphoma. Inflammatory pseudo-
tumors usually present abruptly and are painful, whe-
reas pseudolymphomas are usually painless. Pseu-
dolymphomas are rare nonneoplastic processes that are
pathologically composed of reactive B-cell follicles in a
background infiltrate of T lymphocytes, plasma cells, and
varying degrees of fibrosis (3). They have been repor-
ted in various nodal or extranodal sites, such as skin, brea-
st, lung, pancreas, brain, and liver.
Orbital pseudolymphoma is a partially descriptive
term meaning collections of lymphocytes, often ac-
companied by occasional plasma cells, that accumulate
within particular adnexal locations around the eye (4).
A popular question for the pathologist is: “Is it lympho-
ma or pseudolymphoma?”; the answer is not always ea-
sy, except in the typical cases. 
The diagnostic criteria for the malignant lymphomas
are well established and need not be reiterated here. It
is the pseudolymphomas which merit our recognition
and consideration. Commonly the pseudolymphomas
are extranodal. The gross appearance is not usually help-
ful. Microscopically there is generally preservation of a
follicular pattern with the presence of germinal centres,
although in some instances this may be largely obscu-
red; there is a background suggestive of granulation tis-
sue and a polymorphism of cells but no Reed-Sternberg
cells. There may be discrete or focal granulomas; and fi-
broblastic or fibrocytic proliferation. Giant cells of the
foreign body or Langhans type may be encountered (5). 
Patients usually present with a painless mass in the la-
crimal gland that produces ptosis, proptosis, diplopia, ge-
neralized eye swelling, or disturbance of vision. The mass,
if anterior enough, can be seen as a typical salmon patch
on the conjunctiva or, if deeper, can be imaged with either
computed tomography (CT) or magnetic resonance ima-
ging (MRI). 
Orbital pseudolymphomas are usually idiopathic
and are distributed in the lacrimal gland, conjunctiva,
eyelid, and uvea, in that order of frequency (6). It is not
possible to differentiate a benign from a malignant or-
bital mass on physical examination or by CT or MRI.
Biopsies should be performed on all masses using an ex-
cisional technique to differentiate pseudolymphoma
from lymphoma. Biopsy specimens typically reveal a ch-
ronic inflammatory process composed of numerous hy-
perplastic lymphoid follicles in a background infiltra-
te of T lymphocytes, polytypical plasma cells, and fi-
brosis.
Treatment of pseudolymphomas has traditionally
been with corticosteroids or external beam radiation the-
rapy (EBRT). These treatments are often initially ef-
fective, but patients frequently experience relapse after
corticosteroid therapy has been tapered or require long-
term therapy that is associated with unacceptable adverse
effects (7, 8). Although relapse is less likely with EBRT,
dry eye, cataract, and radiation retinopathy are possible
adverse effects.
Fig. 1 - CT scan shows a right mass in the superior eyelid and lacrimanl gland
extending medially and posteriorly. 
Fig. 2 - Follicles with germinal centres inside lymphoid tissue, incompletely sub-
divided by fibrovascular septa (A). Lacrimal gland with focal lymphocytes and
abundant fibrous tissue (B). Plasma cells positive to kappa (C), and lambda (D)
immunoglobulin heavy chains.
(A, B, haematoxylin and eosin; original magnification: A, x100. B, x200. C, D,
immunohistochemistry, diaminobenzydine; original magnification, x400).
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